{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,8]],"date-time":"2026-09-08T15:23:25Z","timestamp":1788881005501,"version":"build-2803163510"},"reference-count":142,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2026,5,25]],"date-time":"2026-05-25T00:00:00Z","timestamp":1779667200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,5,25]],"date-time":"2026-05-25T00:00:00Z","timestamp":1779667200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"name":"Research Program of Qilu Institute of Technology","award":["QIT25TP001"],"award-info":[{"award-number":["QIT25TP001"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Arch Microbiol"],"published-print":{"date-parts":[[2026,8]]},"DOI":"10.1007\/s00203-026-04972-w","type":"journal-article","created":{"date-parts":[[2026,5,25]],"date-time":"2026-05-25T07:52:58Z","timestamp":1779695578000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Synergistic strategies to rescue the last-resort antibiotic colistin"],"prefix":"10.1007","volume":"208","author":[{"given":"Yaqi","family":"Zhao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liyang","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tianran","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenhui","family":"Diao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hui","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xing","family":"Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ping","family":"Zeng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,5,25]]},"reference":[{"key":"4972_CR1","doi-asserted-by":"publisher","first-page":"487","DOI":"10.1007\/s15010-025-02698-3","volume":"54","author":"S Abaft","year":"2026","unstructured":"Abaft S, Yassin Z, Ahmadinia M, Eshraghi A, Niari BG, Minaeian S, Farasatinasab M (2026) Efficacy and safety of colistin-doxycycline combination therapy in multi-drug resistance Gram-negative infections: a double-blind randomized controlled trial. Infection 54:487\u2013502","journal-title":"Infection"},{"key":"4972_CR2","doi-asserted-by":"publisher","DOI":"10.3390\/antibiotics12020245","volume":"12","author":"ST Abedon","year":"2023","unstructured":"Abedon ST (2023) Ecology and evolutionary biology of hindering phage therapy: the phage tolerance vs. phage resistance of bacterial biofilms. Antibiotics 12:245","journal-title":"Antibiotics"},{"key":"4972_CR3","doi-asserted-by":"publisher","DOI":"10.1002\/hsr2.70956","volume":"8","author":"S Afrasiabi","year":"2025","unstructured":"Afrasiabi S, Partoazar A, Goudarzi R, Dehpour AR (2025) Combined forces against bacteria: phages and antibiotics. Health Sci Rep 8:e70956","journal-title":"Health Sci Rep"},{"key":"4972_CR4","doi-asserted-by":"publisher","first-page":"41","DOI":"10.3390\/tropicalmed7030041","volume":"7","author":"I Alnaami","year":"2022","unstructured":"Alnaami I, Alahmari Z (2022) Intrathecal\/intraventricular colistin for antibiotic-resistant bacterial CNS infections in pediatric population: a systematic review. Trop Med Infect Dis 7:41","journal-title":"Trop Med Infect Dis"},{"key":"4972_CR5","doi-asserted-by":"publisher","first-page":"737","DOI":"10.3390\/ijms27020737","volume":"27","author":"SS Alshatari","year":"2026","unstructured":"Alshatari SS, Ziarno M (2026) From microbes to medicine: targeting metalloprotein pathways for innovative antibacterial strategies. Int J Mol Sci 27:737","journal-title":"Int J Mol Sci"},{"key":"4972_CR6","doi-asserted-by":"publisher","first-page":"9735","DOI":"10.1021\/acs.langmuir.1c01150","volume":"37","author":"J Andersson","year":"2021","unstructured":"Andersson J, Fuller M, Ashenden A, Holt SA, Koper I (2021) Increasing antibiotic susceptibility: the use of cationic gold nanoparticles in Gram-negative bacterial membrane models. Langmuir 37:9735\u20139743","journal-title":"Langmuir"},{"key":"4972_CR7","first-page":"1995","volume":"28","author":"J Antos","year":"2025","unstructured":"Antos J, Wieczorek D, Staszak K, Chou Y-P, Hsu L-H, Shen T-L, Chen Y-L (2025) Transforming otilonium bromide for resilient antimicrobial combat. J Appl Sci Eng 28:1995\u20132003","journal-title":"J Appl Sci Eng"},{"key":"4972_CR8","doi-asserted-by":"publisher","DOI":"10.1186\/s12879-024-09759-2","volume":"24","author":"P Aysert-Yildiz","year":"2024","unstructured":"Aysert-Yildiz P, Ozgen-Top O, Senturk AF, Kanik S, Ozger HS, Dizbay M (2024) Polymyxin B vs. colistin: the comparison of neurotoxic and nephrotoxic effects of the two polymyxins. BMC Infect Dis 24:862","journal-title":"BMC Infect Dis"},{"key":"4972_CR9","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1097\/IM9.0000000000000002","volume":"1","author":"B Berglund","year":"2019","unstructured":"Berglund B (2019) Acquired resistance to colistin via chromosomal and plasmid-mediated mechanisms in Klebsiella pneumoniae. Infect Microbe Dis 1:10\u201319","journal-title":"Infect Microbe Dis"},{"key":"4972_CR10","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijantimicag.2020.105901","volume":"55","author":"A Bidaud","year":"2020","unstructured":"Bidaud A, Djenontin E, Botterel F, Chowdhary A, Dannaoui E (2020) Colistin interacts synergistically with echinocandins against Candida auris. Int J Antimicrob Agents 55:105901","journal-title":"Int J Antimicrob Agents"},{"key":"4972_CR11","doi-asserted-by":"publisher","first-page":"761","DOI":"10.3390\/antibiotics14080761","volume":"14","author":"E Bonnet","year":"2025","unstructured":"Bonnet E, Lourtet-Hascoet J (2025) Combination antibiotic therapy for orthopedic infections. Antibiotics Basel 14:761","journal-title":"Antibiotics Basel"},{"key":"4972_CR12","doi-asserted-by":"publisher","DOI":"10.3390\/antibiotics13070630","volume":"13","author":"N Changsan","year":"2024","unstructured":"Changsan N, Atipairin A, Muenraya P, Sritharadol R, Srichana T, Balekar N, Sawatdee S (2024) In vitro evaluation of colistin conjugated with chitosan-capped gold nanoparticles as a possible formulation applied in a metered-dose inhaler. Antibiotics Basel 13:630","journal-title":"Antibiotics Basel"},{"key":"4972_CR13","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-025-01303-9","volume":"15","author":"C Chatupheeraphat","year":"2025","unstructured":"Chatupheeraphat C, Kaewsai N, Anuwongcharoen N, Phanus-Umporn C, Pornsuwan S, Eiamphungporn W (2025) Penfluridol synergizes with colistin to reverse colistin resistance in Gram-negative bacilli. Sci Rep 15:16114","journal-title":"Sci Rep"},{"key":"4972_CR14","doi-asserted-by":"publisher","first-page":"810","DOI":"10.1038\/s42003-023-05173-7","volume":"6","author":"C Chen","year":"2023","unstructured":"Chen C, Cai J, Shi J, Wang Z, Liu Y (2023) Resensitizing multidrug-resistant Gram-negative bacteria to carbapenems and colistin using disulfiram. Commun Biol 6:810","journal-title":"Commun Biol"},{"key":"4972_CR15","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijantimicag.2023.107066","volume":"63","author":"H Chen","year":"2024","unstructured":"Chen H, Hu P, Liu H, Liu S, Liu Y, Chen L, Feng L, Chen L, Zhou T (2024) Combining with Domiphen bromide restores colistin efficacy against colistin-resistant Gram-negative bacteria in vitro and in vivo. Int J Antimicrob Agents 63:107066","journal-title":"Int J Antimicrob Agents"},{"key":"4972_CR16","doi-asserted-by":"publisher","DOI":"10.1016\/j.jddst.2025.107216","volume":"111","author":"S-Y Chen","year":"2025","unstructured":"Chen S-Y, Liew K, Lin H-L, Chien J-Y, Chan H-K, Ke W-R (2025) Inline nebulized aerosol delivery of colistin methanesulfonate via high-flow nasal cannula system. J Drug Deliv Sci Tec 111:107216","journal-title":"J Drug Deliv Sci Tec"},{"key":"4972_CR17","doi-asserted-by":"publisher","first-page":"32373","DOI":"10.1007\/s11356-018-3217-2","volume":"25","author":"Z Chi","year":"2018","unstructured":"Chi Z, Lin H, Li W, Zhang X, Zhang Q (2018) In vitro assessment of the toxicity of small silver nanoparticles and silver ions to the red blood cells. Environ Sci Pollut Res Int 25:32373\u201332380","journal-title":"Environ Sci Pollut Res Int"},{"key":"4972_CR18","doi-asserted-by":"publisher","DOI":"10.1128\/spectrum.00855-25","volume":"13","author":"Y-J Choi","year":"2025","unstructured":"Choi Y-J, Shamsuzzaman M, Park C, Kim S, Shin M, Kim J (2025) Overcoming phage resistance: efficacy of sequential phage-colistin therapy against carbapenem-resistant Acinetobacter baumannii. Microbiol Spectr 13:e00855-00825","journal-title":"Microbiol Spectr"},{"key":"4972_CR19","doi-asserted-by":"publisher","DOI":"10.3390\/antibiotics12010081","volume":"12","author":"S Chosidow","year":"2023","unstructured":"Chosidow S, Fantin B, Nicolas I, Mascary JB, Chau F, Bordeau V, Verdier MC, Rocheteau P, Guerin F, Cattoir V, De Lastours V (2023) Synergistic activity of Pep16, a promising new antibacterial pseudopeptide against multidrug-resistant organisms, in combination with colistin against multidrug-resistant Escherichia coli, in vitro and in a murine peritonitis model. Antibiotics Basel 12:81","journal-title":"Antibiotics Basel"},{"key":"4972_CR20","doi-asserted-by":"publisher","DOI":"10.1128\/spectrum.04275-22","volume":"11","author":"D Collalto","year":"2023","unstructured":"Collalto D, Fortuna A, Visca P, Imperi F, Rampioni G, Leoni L (2023) Synergistic activity of colistin in combination with clofoctol against colistin resistant Gram-negative pathogens. Microbiol Spectr 11:e04275-04222","journal-title":"Microbiol Spectr"},{"key":"4972_CR21","doi-asserted-by":"publisher","first-page":"961","DOI":"10.1021\/acsinfecdis.3c00591","volume":"10","author":"R Cui","year":"2024","unstructured":"Cui R, Zhang J, Liu X, Hu C, Zhou F, Zhang M, Wang X, Zou Q, Huang W (2024) Dronedarone enhances the antibacterial activity of polymyxin B and inhibits the quorum sensing system by interacting with LuxS. ACS Infect Dis 10:961\u2013970","journal-title":"ACS Infect Dis"},{"key":"4972_CR22","doi-asserted-by":"publisher","first-page":"1534","DOI":"10.1002\/ddr.21990","volume":"83","author":"G Da Costa De Souza","year":"2022","unstructured":"Da Costa De Souza G, Roque-Borda CA, Pavan FR (2022) Beta-lactam resistance and the effectiveness of antimicrobial peptides against KPC-producing bacteria. Drug Dev Res 83:1534\u20131554","journal-title":"Drug Dev Res"},{"key":"4972_CR23","doi-asserted-by":"publisher","first-page":"7271","DOI":"10.2147\/IDR.S318173","volume":"15","author":"D De La Rosa-Carrillo","year":"2022","unstructured":"De La Rosa-Carrillo D, Suarez-Cuartin G, Golpe R, Maiz Carro L, Martinez-Garcia MA (2022) Inhaled colistimethate sodium in the management of patients with bronchiectasis infected by Pseudomonas aeruginosa: a narrative review of current evidence. Infect Drug Resist 15:7271\u20137292","journal-title":"Infect Drug Resist"},{"key":"4972_CR24","doi-asserted-by":"publisher","DOI":"10.1186\/s13613-024-01384-1","volume":"14","author":"G De Pascale","year":"2024","unstructured":"De Pascale G, Lisi L, Cutuli SL, Marinozzi C, Palladini A, Ferrando ES, Tanzarella ES, Lombardi G, Grieco DL, Caroli A, Xhemalaj R, Cascarano L, Ciotti GMP, Sandroni C, Sanguinetti M, Navarra P, Antonelli M (2024) High-dose colistin pharmacokinetics in critically ill patients receiving continuous renal replacement therapy. Ann Intensive Care 14:152","journal-title":"Ann Intensive Care"},{"key":"4972_CR25","doi-asserted-by":"publisher","DOI":"10.3390\/molecules29132969","volume":"29","author":"E Diani","year":"2024","unstructured":"Diani E, Bianco G, Gatti M, Gibellini D, Gaibani P (2024) Colistin: lights and shadows of an older antibiotic. Molecules (Basel) 29:2969","journal-title":"Molecules (Basel)"},{"key":"4972_CR26","doi-asserted-by":"publisher","DOI":"10.3389\/fmicb.2023.1207441","volume":"14","author":"Y Ding","year":"2023","unstructured":"Ding Y, Hao J, Xiao W, Ye C, Xiao X, Jian C, Tang M, Li G, Liu J, Zeng Z (2023) Role of efflux pumps, their inhibitors, and regulators in colistin resistance. Front Microbiol 14:1207441","journal-title":"Front Microbiol"},{"key":"4972_CR27","doi-asserted-by":"publisher","first-page":"497","DOI":"10.3390\/antibiotics14050497","volume":"14","author":"J Eudy","year":"2025","unstructured":"Eudy J, Chase AM, Sharma D, Sulaiman ZI, Anderson A, Huggett A, Gloe L, Anderson DT (2025) Evaluation of adjunctive aminoglycoside therapy compared to beta-lactam monotherapy in critically ill patients with gram-negative bloodstream infections. Antibiotics (Basel) 14:497","journal-title":"Antibiotics (Basel)"},{"key":"4972_CR28","doi-asserted-by":"publisher","first-page":"928","DOI":"10.1016\/j.sjbs.2020.09.064","volume":"28","author":"AO Fadwa","year":"2021","unstructured":"Fadwa AO, Alkoblan DK, Mateen A, Albarag AM (2021) Synergistic effects of zinc oxide nanoparticles and various antibiotics combination against Pseudomonas aeruginosa clinically isolated bacterial strains. Saudi J Biol Sci 28:928\u2013935","journal-title":"Saudi J Biol Sci"},{"key":"4972_CR29","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1016\/j.jhin.2025.10.019","volume":"167","author":"ME Falagas","year":"2026","unstructured":"Falagas ME, Kontogiannis DS, Sargianou M, Bousi SE, Ntourakis D (2026) Colistin monotherapy versus colistin combination therapy in the treatment of patients with multidrug-resistant and extensively drug-resistant Acinetobacter baumannii infections: a meta-analysis. J Hosp Infect 167:211\u2013231","journal-title":"J Hosp Infect"},{"key":"4972_CR30","doi-asserted-by":"publisher","DOI":"10.3389\/fmicb.2021.676414","volume":"12","author":"X Feng","year":"2021","unstructured":"Feng X, Liu S, Wang Y, Zhang Y, Sun L, Li H, Wang C, Liu Y, Cao B (2021) Synergistic activity of colistin combined with auranofin against colistin-resistant gram-negative bacteria. Front Microbiol 12:676414","journal-title":"Front Microbiol"},{"key":"4972_CR31","doi-asserted-by":"publisher","DOI":"10.1016\/j.resmic.2022.103993","volume":"174","author":"BN Fortes","year":"2023","unstructured":"Fortes BN, Scheunemann G, De Azevedo Melo AS, Ishida K (2023) Caspofungin alone or combined with polymyxin B are effective against mixed biofilm of Aspergillus fumigatus and carbapenem-resistant Pseudomonas aeruginosa. Res Microbiol 174:103993","journal-title":"Res Microbiol"},{"key":"4972_CR32","doi-asserted-by":"publisher","first-page":"2175","DOI":"10.2147\/IDR.S512403","volume":"18","author":"W Gao","year":"2025","unstructured":"Gao W, Li W, Liu H, Xu D, Tian L, Zhang J, Liu D, He Y (2025) Factors associated with successful treatment of carbapenem-resistant gram-negative bacilli infections using intravenous colistin sulfate in China: a real-world retrospective study. Infect Drug Resist 18:2175\u20132185","journal-title":"Infect Drug Resist"},{"key":"4972_CR33","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-025-60991-z","volume":"16","author":"LC Garc\u00eda Carnero","year":"2025","unstructured":"Garc\u00eda Carnero LC, Li X, De Castro PA, Pinzan CF, Campanella JEM, Malavazi I, Yoshimura M, Isuhuaylas LaV, Yashiroda Y, Boone C (2025) Colistin enhances caspofungin antifungal efficacy against Aspergillus fumigatus by modulating calcium homeostasis and stress responses. Nat Commun 16:5967","journal-title":"Nat Commun"},{"key":"4972_CR34","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1159\/000356004","volume":"59","author":"J Garnacho-Montero","year":"2014","unstructured":"Garnacho-Montero J, Amaya-Villar R, Guti\u00e9rrez-Pizarraya A, Espejo-Guti\u00e9rrez De Tena E, Artero-Gonz\u00e1lez ML, Corcia-Palomo Y, Bautista-Paloma J (2014) Clinical efficacy and safety of the combination of colistin plus vancomycin for the treatment of severe infections caused by carbapenem-resistant Acinetobacter baumannii. Chemotherapy 59:225\u2013231","journal-title":"Chemotherapy"},{"key":"4972_CR35","doi-asserted-by":"publisher","DOI":"10.3389\/fvets.2023.1153048","volume":"10","author":"R Gehring","year":"2023","unstructured":"Gehring R, Mochel JP, Schmerold I (2023) Understanding the background and clinical significance of the WHO, WOAH, and EMA classifications of antimicrobials to mitigate antimicrobial resistance. Front Vet Sci 10:1153048","journal-title":"Front Vet Sci"},{"key":"4972_CR36","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1007\/s00203-025-04483-0","volume":"207","author":"EA George","year":"2025","unstructured":"George EA, Naha A, Ramaiah S (2025) Novel antimicrobial peptide HFIAP-1 mutant as a \u03b2-lactamase inhibitor against extended-spectrum \u03b2-lactamases of Escherichia coli: a comprehensive in-silico approach. Arch Microbiol 207:279","journal-title":"Arch Microbiol"},{"key":"4972_CR37","doi-asserted-by":"publisher","first-page":"1317","DOI":"10.1007\/s12602-025-10608-0","volume":"18","author":"EA George","year":"2026","unstructured":"George EA, Naha A, Soundharya H, Pallavi J, Menon A, Anbarasu A, Ramaiah S (2026) Pharmacokinetics screening, molecular docking, and dynamics simulations revealed novel antimicrobial peptide NKLF2 mutants as potent inhibitors of Mycobacterium tuberculosis. Probiotics Antimicrob Proteins 18:1317\u20131337","journal-title":"Probiotics Antimicrob Proteins"},{"key":"4972_CR38","doi-asserted-by":"publisher","DOI":"10.1128\/jcm.00276-21","volume":"60","author":"CG Giske","year":"2022","unstructured":"Giske CG, Turnidge J, Cant\u00f3n R, Kahlmeter G (2022) Update from the European committee on antimicrobial susceptibility testing (EUCAST). J Clin Microbiol 60:e00276-00221","journal-title":"J Clin Microbiol"},{"key":"4972_CR39","doi-asserted-by":"publisher","DOI":"10.3389\/fmed.2021.677720","volume":"8","author":"FA Gogry","year":"2021","unstructured":"Gogry FA, Siddiqui MT, Sultan I, Haq QMR (2021) Current update on intrinsic and acquired colistin resistance mechanisms in bacteria. Front Med 8:677720","journal-title":"Front Med"},{"key":"4972_CR40","doi-asserted-by":"publisher","DOI":"10.1016\/j.ebiom.2022.104045","volume":"80","author":"FL Gordillo Altamirano","year":"2022","unstructured":"Gordillo Altamirano FL, Kostoulias X, Subedi D, Korneev D, Peleg AY, Barr JJ (2022) Phage-antibiotic combination is a superior treatment against Acinetobacter baumannii in a preclinical study. EBioMedicine 80:104045","journal-title":"EBioMedicine"},{"key":"4972_CR41","doi-asserted-by":"publisher","first-page":"1441","DOI":"10.1007\/s40262-017-0561-1","volume":"56","author":"N Gr\u00e9goire","year":"2017","unstructured":"Gr\u00e9goire N, Aranzana-Climent V, Magr\u00e9ault S, Marchand S, Couet W (2017) Clinical pharmacokinetics and pharmacodynamics of colistin. Clin Pharmacokinet 56:1441\u20131460","journal-title":"Clin Pharmacokinet"},{"key":"4972_CR42","doi-asserted-by":"publisher","first-page":"726","DOI":"10.1016\/S1473-3099(17)30228-1","volume":"17","author":"B Gutierrez-Gutierrez","year":"2017","unstructured":"Gutierrez-Gutierrez B, Salamanca E, De Cueto M, Hsueh PR, Viale P, Pano-Pardo JR, Venditti M, Tumbarello M, Daikos G, Canton R, Doi Y, Tuon FF, Karaiskos I, Perez-Nadales E, Schwaber MJ, Azap OK, Souli M, Roilides E, Pournaras S, Akova M, Perez F, Bermejo J, Oliver A, Almela M, Lowman W, Almirante B, Bonomo RA, Carmeli Y, Paterson DL, Pascual A, Rodriguez-Bano J, Investigators REI (2017) Effect of appropriate combination therapy on mortality of patients with bloodstream infections due to carbapenemase-producing Enterobacteriaceae (INCREMENT): a retrospective cohort study. Lancet Infect Dis 17:726\u2013734","journal-title":"Lancet Infect Dis"},{"key":"4972_CR43","doi-asserted-by":"publisher","first-page":"4811","DOI":"10.1007\/s10904-020-01744-x","volume":"30","author":"A Hamad","year":"2020","unstructured":"Hamad A, Khashan KS, Hadi A (2020) Silver nanoparticles and silver ions as potential antibacterial agents. J Inorg Organomet Polym Mater 30:4811\u20134828","journal-title":"J Inorg Organomet Polym Mater"},{"key":"4972_CR44","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.2515303123","volume":"123","author":"J Hernandez-Bird","year":"2026","unstructured":"Hernandez-Bird J, He B, Vanotterloo LM, Billings EB, Huo W, Teodoro GIC, Echlin H, Rosch JM, Trent MS, Isberg RR (2026) Resistance, heteroresistance, and fitness costs drive colistin treatment failure during Acinetobacter baumannii pneumonia. Proc Natl Acad Sci U S A 123:e2515303123","journal-title":"Proc Natl Acad Sci U S A"},{"key":"4972_CR45","doi-asserted-by":"crossref","unstructured":"Huralska M, Pogue JM, Rybak M, Abdul-Mutakabbir JC, Stamper K, Marchaim D, Thamlikitkul V, Carmeli Y, Chiu CH, Daikos G, Dhar S, Durante-Mangoni E, Gikas A, Kotanidou A, Paul M, Roilides E, Samarkos M, Sims M, Tancheva D, Tsiodras S, Kett DH, Patel G, Calfee DP, Leibovici L, Power L, Munoz-Price S, Shaikh H, Susick L, Latack K, Chiou C, Divine G, Ghazyaran V & Kaye KS (2025) The impact of synergistic therapy between colistin and meropenem on outcomes of patients with pneumonia or bloodstream infection due to carbapenem-resistant Gram-negative pathogens. Clin Infect Dis:ciaf398.","DOI":"10.1093\/cid\/ciaf398"},{"key":"4972_CR46","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1007\/s00203-026-04855-0","volume":"208","author":"J Idrees","year":"2026","unstructured":"Idrees J, Shabbir AQ, Alvi IA, Sana S, Rehman SU, Asif M (2026) CRISPR-anti-CRISPR dynamics: evolutionary, ecological and biotechnological perspectives. Arch Microbiol 208:289","journal-title":"Arch Microbiol"},{"key":"4972_CR47","doi-asserted-by":"publisher","DOI":"10.3390\/pathogens13121049","volume":"13","author":"MM Islam","year":"2024","unstructured":"Islam MM, Jung DE, Shin WS, Oh MH (2024) Colistin resistance mechanism and management strategies of colistin-resistant Acinetobacter baumannii infections. Pathogens 13:1049","journal-title":"Pathogens"},{"key":"4972_CR48","doi-asserted-by":"publisher","DOI":"10.1016\/j.micpath.2020.104700","volume":"150","author":"A Jahangiri","year":"2021","unstructured":"Jahangiri A, Neshani A, Mirhosseini SA, Ghazvini K, Zare H, Sedighian H (2021) Synergistic effect of two antimicrobial peptides, Nisin and P10 with conventional antibiotics against extensively drug-resistant Acinetobacter baumannii and colistin-resistant Pseudomonas aeruginosa isolates. Microb Pathog 150:104700","journal-title":"Microb Pathog"},{"key":"4972_CR49","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1007\/s42770-023-01189-7","volume":"55","author":"AT Jalil","year":"2024","unstructured":"Jalil AT, Alrawe RTA, Al-Saffar MA, Shaghnab ML, Merza MS, Abosaooda M, Latef R (2024) The use of combination therapy for the improvement of colistin activity against bacterial biofilm. Braz J Microbiol 55:411\u2013427","journal-title":"Braz J Microbiol"},{"key":"4972_CR50","doi-asserted-by":"publisher","DOI":"10.4014\/jmb.2601.01019","volume":"36","author":"J Jo","year":"2026","unstructured":"Jo J, Myung H (2026) Comparative combinatorial effects of endolysins LNT103 with ten conventional antibiotics against Gram-negative bacterial pathogens. J Microbiol Biotechnol 36:e2601019","journal-title":"J Microbiol Biotechnol"},{"key":"4972_CR51","doi-asserted-by":"publisher","first-page":"523","DOI":"10.1080\/17460913.2025.2490377","volume":"20","author":"E Karaaslan","year":"2025","unstructured":"Karaaslan E, Oyardi O, Dosler S (2025) Enhancing colistin efficacy with combination therapies for multidrug-resistant P. aeruginosa and A. baumannii isolates. Future Microbiol 20:523\u2013531","journal-title":"Future Microbiol"},{"key":"4972_CR52","doi-asserted-by":"publisher","first-page":"2497","DOI":"10.1093\/jac\/dkz165","volume":"74","author":"SA Karageorgos","year":"2019","unstructured":"Karageorgos SA, Bassiri H, Siakallis G, Miligkos M, Tsioutis C (2019) Intravenous colistin use for infections due to MDR Gram-negative bacilli in critically ill paediatric patients: a systematic review and meta-analysis. J Antimicrob Chemother 74:2497\u20132506","journal-title":"J Antimicrob Chemother"},{"key":"4972_CR53","doi-asserted-by":"publisher","DOI":"10.1056\/EVIDoa2200131","volume":"2","author":"KS Kaye","year":"2023","unstructured":"Kaye KS, Marchaim D, Thamlikitkul V, Carmeli Y, Chiu CH, Daikos G, Dhar S, Durante-Mangoni E, Gikas A, Kotanidou A, Paul M, Roilides E, Rybak M, Samarkos M, Sims M, Tancheva D, Tsiodras S, Kett D, Patel G, Calfee D, Leibovici L, Power L, Munoz-Price S, Stevenson K, Susick L, Latack K, Daniel J, Chiou C, Divine GW, Ghazyaran V, Pogue JM (2023) Colistin monotherapy versus combination therapy for carbapenem-resistant organisms. NEJM Evid 2:EVIDoa2200131","journal-title":"NEJM Evid"},{"key":"4972_CR54","doi-asserted-by":"publisher","first-page":"65","DOI":"10.4103\/jrpp.jrpp_51_24","volume":"13","author":"M Kazemi Najafabadi","year":"2024","unstructured":"Kazemi Najafabadi M, Alikiaei B, Khorvash F, Shafiee F, Soltani R (2024) The effectiveness of colistin\/rifampin compared to colistin\/meropenem in the treatment of ventilator-associated pneumonia caused by carbapenem-resistant Acinetobacter baumannii: a randomized controlled clinical trial. J Res Pharm Pract 13:65\u201371","journal-title":"J Res Pharm Pract"},{"key":"4972_CR55","doi-asserted-by":"publisher","first-page":"1253","DOI":"10.2147\/IDR.S493635","volume":"18","author":"Y Ke","year":"2025","unstructured":"Ke Y, Zeng Z, Liu J, Ye C (2025) Capsular polysaccharide as a potential target in hypervirulent and drug-resistant Klebsiella pneumoniae treatment. Infect Drug Resist 18:1253\u20131262","journal-title":"Infect Drug Resist"},{"key":"4972_CR56","doi-asserted-by":"publisher","first-page":"e00809","DOI":"10.1128\/aac.00809-25","volume":"69","author":"J Kent","year":"2025","unstructured":"Kent J, Elane M, Leyn S, Zlamal J, Wong N, Aizin M, Zampaloni C, Louvel S, Haldimann A, Vercruysse M (2025) Mutations in two-component signaling systems drive experimental evolution of tigecycline and colistin resistance in Acinetobacter baumannii. Antimicrob Agents Chemother 69:e00809-00825","journal-title":"Antimicrob Agents Chemother"},{"key":"4972_CR57","doi-asserted-by":"publisher","DOI":"10.1186\/s12879-025-10600-7","volume":"25","author":"S Khoshnood","year":"2025","unstructured":"Khoshnood S, Haddadi MH, Sadeghifard N, Maleki A, Kouhsari E, Valadbeigi H (2025) Systematic review and meta-analysis of colistin heteroresistance in Klebsiella pneumoniae isolates. BMC Infect Dis 25:207","journal-title":"BMC Infect Dis"},{"key":"4972_CR58","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1016\/j.ijantimicag.2014.01.020","volume":"43","author":"J Kim","year":"2014","unstructured":"Kim J, Kang CI, Baek JY, Cho SY, Kim SH, Ko KS, Chung DR, Peck KR, Song JH (2014) Treatment failure due to induction of ciprofloxacin resistance during combination therapy with colistin and ciprofloxacin in multidrug-resistant Pseudomonas aeruginosa bacteraemia. Int J Antimicrob Agents 43:391\u2013393","journal-title":"Int J Antimicrob Agents"},{"key":"4972_CR59","doi-asserted-by":"publisher","DOI":"10.3346\/jkms.2023.38.e263","volume":"38","author":"SH Kim","year":"2023","unstructured":"Kim SH, Wi YM, Peck KR (2023) Clinical effectiveness of tetracycline-class agents based regimens in patients with carbapenem-resistant Acinetobacter baumannii bacteremia: a single-center retrospective cohort study. J Korean Med Sci 38:e263","journal-title":"J Korean Med Sci"},{"key":"4972_CR60","doi-asserted-by":"publisher","DOI":"10.3389\/fmicb.2022.1006604","volume":"13","author":"D Kumar","year":"2023","unstructured":"Kumar D, Singhal C, Yadav M, Joshi P, Patra P, Tanwar S, Das A, Pramanik SK, Chaudhuri S (2023) Colistin potentiation in multidrug-resistant Acinetobacter baumannii by a non-cytotoxic guanidine derivative of silver. Front Microbiol 13:1006604","journal-title":"Front Microbiol"},{"key":"4972_CR61","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijpharm.2023.122732","volume":"635","author":"G Landa","year":"2023","unstructured":"Landa G, Alejo T, Sauzet T, Laroche J, Sebastian V, Tewes F, Arruebo M (2023) Colistin-loaded aerosolizable particles for the treatment of bacterial respiratory infections. Int J Pharm 635:122732","journal-title":"Int J Pharm"},{"key":"4972_CR62","doi-asserted-by":"publisher","DOI":"10.3390\/ijms27073115","volume":"27","author":"W Lewandowska","year":"2026","unstructured":"Lewandowska W, Swiecicka I (2026) Perspectives on colistin - an old antibiotic with renewed relevance in modern medicine. Int J Mol Sci 27:3115","journal-title":"Int J Mol Sci"},{"key":"4972_CR63","doi-asserted-by":"publisher","DOI":"10.3389\/fmicb.2019.03015","volume":"10","author":"B Li","year":"2019","unstructured":"Li B, Yin F, Zhao X, Guo Y, Wang W, Wang P, Zhu H, Yin Y, Wang X (2019) Colistin resistance gene mcr-1 mediates cell permeability and resistance to hydrophobic antibiotics. Front Microbiol 10:3015","journal-title":"Front Microbiol"},{"key":"4972_CR64","doi-asserted-by":"publisher","DOI":"10.3389\/fmicb.2024.1447485","volume":"15","author":"H Li","year":"2024","unstructured":"Li H, Zhu X, Zhang X, Dong C (2024) Caspofungin enhances the potency of rifampin against Gram-negative bacteria. Front Microbiol 15:1447485","journal-title":"Front Microbiol"},{"key":"4972_CR65","doi-asserted-by":"publisher","first-page":"1279","DOI":"10.1592\/phco.30.12.1279","volume":"30","author":"LM Lim","year":"2010","unstructured":"Lim LM, Ly N, Anderson D, Yang JC, Macander L, Jarkowski A 3rd, Forrest A, Bulitta JB, Tsuji BT (2010) Resurgence of colistin: a review of resistance, toxicity, pharmacodynamics, and dosing. Pharmacotherapy 30:1279\u20131291","journal-title":"Pharmacotherapy"},{"key":"4972_CR66","doi-asserted-by":"publisher","DOI":"10.3390\/ijms26073312","volume":"26","author":"T Lin","year":"2025","unstructured":"Lin T, Liu S, Chen X, Gao F, Liu L, Chen D, Yin Y (2025) Synergistic antibacterial activity of amorolfine combined with colistin against Acinetobacter baumannii. Int J Mol Sci 26:3312","journal-title":"Int J Mol Sci"},{"key":"4972_CR67","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1016\/S1473-3099(15)00424-7","volume":"16","author":"Y-Y Liu","year":"2016","unstructured":"Liu Y-Y, Wang Y, Walsh TR, Yi L-X, Zhang R, Spencer J, Doi Y, Tian G, Dong B, Huang X (2016) Emergence of plasmid-mediated colistin resistance mechanism MCR-1 in animals and human beings in China: a microbiological and molecular biological study. Lancet Infect Dis 16:161\u2013168","journal-title":"Lancet Infect Dis"},{"key":"4972_CR68","doi-asserted-by":"publisher","first-page":"1961","DOI":"10.1016\/j.drudis.2022.02.010","volume":"27","author":"Y Liu","year":"2022","unstructured":"Liu Y, Lu Y, Xu Z, Ma X, Chen X, Liu W (2022) Repurposing of the gold drug auranofin and a review of its derivatives as antibacterial therapeutics. Drug Discov Today 27:1961\u20131973","journal-title":"Drug Discov Today"},{"key":"4972_CR69","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1016\/j.tim.2023.10.006","volume":"32","author":"JH Liu","year":"2024","unstructured":"Liu JH, Liu YY, Shen YB, Yang J, Walsh TR, Wang Y, Shen J (2024) Plasmid-mediated colistin-resistance genes: mcr. Trends Microbiol 32:365\u2013378","journal-title":"Trends Microbiol"},{"key":"4972_CR70","doi-asserted-by":"publisher","DOI":"10.1128\/spectrum.01196-25","volume":"13","author":"Z Liu","year":"2025","unstructured":"Liu Z, Liu M, Wang Z, Jiang C, Wang J, Deng X, Liu H, Deng Y, Qiu J (2025) Dronedarone hydrochloride targets cardiolipin and phosphatidylglycerol to increase colistin susceptibility in gram-negative pathogens. Microbiol Spectr 13:e01196-01125","journal-title":"Microbiol Spectr"},{"key":"4972_CR71","volume":"42","author":"J Lu","year":"2025","unstructured":"Lu J, Shi Y, Pan Y, Grossart H-P, Mei L, Xie D, Guan W, Zhang H, Lou Y (2025) Repurposing auranofin combined with colistin to effectively combat fish-pathogenic Edwardsiella piscicida. Aquacult Rep 42:102830","journal-title":"Aquacult Rep"},{"key":"4972_CR72","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1007\/s44446-025-00049-9","volume":"33","author":"MA Mahmoud","year":"2025","unstructured":"Mahmoud MA, Alharbi M (2025) Molecular mechanisms attributed to colistin renal proximal tubular epithelial cytotoxicity. Saudi Pharm J 33:45","journal-title":"Saudi Pharm J"},{"key":"4972_CR73","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1007\/s15010-024-02379-7","volume":"53","author":"M Manche\u00f1o-Losa","year":"2025","unstructured":"Manche\u00f1o-Losa M, Murillo O, Benavent E, Sorl\u00ed L, Riera M, Cobo J, Benito N, Morata L, Ribera A, Sobrino B (2025) Efficacy and safety of colistin plus beta-lactams for bone and joint infection caused by fluoroquinolone-resistant gram-negative bacilli: a prospective multicenter study. Infection 53:359\u2013372","journal-title":"Infection"},{"key":"4972_CR74","doi-asserted-by":"publisher","first-page":"2351","DOI":"10.1007\/s40121-024-01042-w","volume":"13","author":"A Manesh","year":"2024","unstructured":"Manesh A, George MM, Palanikumar P, Nagaraj V, Bhanuprasad K, Krishnan R, Nivetha G, Lal B, Triveni KR, Gautam P, George B, Kulkarni U, Mathews V, Subramani K, Rao S, Chacko B, Zachariah A, Sathyendra S, Hansdak SG, Abraham OC, Iyadurai R, Karthik R, Peter JV, Mo Y, Veeraraghavan B, Varghese GM, Paterson DL (2024) Combination versus monotherapy for carbapenem-resistant Acinetobacter species serious infections: a prospective IPTW adjusted cohort study. Infect Dis Ther 13:2351\u20132362","journal-title":"Infect Dis Ther"},{"key":"4972_CR75","doi-asserted-by":"publisher","first-page":"563","DOI":"10.1080\/1040841X.2024.2390597","volume":"51","author":"T Manobala","year":"2025","unstructured":"Manobala T (2025) Peptide-based strategies for overcoming biofilm-associated infections: a comprehensive review. Crit Rev Microbiol 51:563\u2013580","journal-title":"Crit Rev Microbiol"},{"key":"4972_CR76","doi-asserted-by":"publisher","first-page":"2094","DOI":"10.1093\/jac\/dkac145","volume":"77","author":"I Margalit","year":"2022","unstructured":"Margalit I, Prendki V, Tishler O, Falcone M, Tiseo G, Leibovici-Weissman Y, Paul M, Yahav D, Elderly ESGFIIT (2022) Effectiveness and safety of colistin among older adults: a systematic review and meta-analysis. J Antimicrob Chemother 77:2094\u20132104","journal-title":"J Antimicrob Chemother"},{"key":"4972_CR77","doi-asserted-by":"publisher","first-page":"5211","DOI":"10.2147\/IJGM.S357427","volume":"15","author":"F Mariano","year":"2022","unstructured":"Mariano F, Malvasio V, Risso D, Depetris N, Pensa A, Fucale G, Gennari F, Biancone L, Stella M (2022) Colistin therapy, survival and renal replacement therapy in burn patients: a 10-year single-center cohort study. Int J Gen Med 15:5211\u20135221","journal-title":"Int J Gen Med"},{"key":"4972_CR78","doi-asserted-by":"publisher","DOI":"10.4081\/idr.2012.e36","volume":"4","author":"I May","year":"2012","unstructured":"May I, Abu-Khdeir M, Blackwood RA (2012) An usual approach to treatment of a case of multidrug resistance Pseudomonas aeruginosa peritonitis: parenteral and intraperitoneal aminoglycosides and parenteral colistin. Infect Dis Rep 4:e36","journal-title":"Infect Dis Rep"},{"key":"4972_CR79","doi-asserted-by":"publisher","DOI":"10.3389\/fmicb.2023.1030401","volume":"14","author":"R Mirzaei","year":"2023","unstructured":"Mirzaei R, Esmaeili Gouvarchin Ghaleh H, Ranjbar R (2023) Antibiofilm effect of melittin alone and in combination with conventional antibiotics toward strong biofilm of MDR-MRSA and -Pseudomonas aeruginosa. Front Microbiol 14:1030401","journal-title":"Front Microbiol"},{"key":"4972_CR80","doi-asserted-by":"publisher","first-page":"e03006","DOI":"10.1128\/spectrum.03006-25","volume":"14","author":"MF Mohamed","year":"2026","unstructured":"Mohamed MF, Abdelmegeed SM, Abdelsattar AS, Abouelkhair AA, Abutaleb NS, Seleem MN (2026) Dronedarone synergizes with colistin against planktonic and biofilm forms of multidrug-resistant Gram-negative pathogens. Microbiol Spectr 14:e03006-03025","journal-title":"Microbiol Spectr"},{"key":"4972_CR81","doi-asserted-by":"publisher","first-page":"2365","DOI":"10.2147\/COPD.S209513","volume":"14","author":"C Monton","year":"2019","unstructured":"Monton C, Prina E, Pomares X, Cugat JR, Casabella A, Oliva JC, Gallego M, Monso E (2019) Nebulized colistin and continuous cyclic azithromycin in severe COPD patients with chronic bronchial infection due to Pseudomonas aeruginosa: a retrospective cohort study. Int J Chron Obstruct Pulmon Dis 14:2365\u20132373","journal-title":"Int J Chron Obstruct Pulmon Dis"},{"key":"4972_CR82","doi-asserted-by":"publisher","first-page":"221","DOI":"10.2217\/fmb-2020-0204","volume":"16","author":"G Morroni","year":"2021","unstructured":"Morroni G, Sante LD, Simonetti O, Brescini L, Kamysz W, Kamysz E, Mingoia M, Brenciani A, Giovanetti E, Bagnarelli P (2021) Synergistic effect of antimicrobial peptide LL-37 and colistin combination against multidrug-resistant Escherichia coli isolates. Future Microbiol 16:221\u2013227","journal-title":"Future Microbiol"},{"key":"4972_CR83","doi-asserted-by":"publisher","first-page":"159","DOI":"10.4103\/jrpp.jrpp_90_21","volume":"10","author":"S Mosayebi","year":"2021","unstructured":"Mosayebi S, Soltani R, Shafiee F, Assarzadeh S, Hakamifard A (2021) Evaluation of the effectiveness of N-acetylcysteine in the prevention of colistin-induced nephrotoxicity: a randomized controlled clinical trial. J Res Pharm Pract 10:159\u2013165","journal-title":"J Res Pharm Pract"},{"key":"4972_CR84","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1039\/D3BM01383A","volume":"12","author":"S Mukhopadhyay","year":"2024","unstructured":"Mukhopadhyay S, To KKW, Liu Y, Bai C, Leung SSY (2024) A thermosensitive hydrogel formulation of phage and colistin combination for the management of multidrug-resistant Acinetobacter baumannii wound infections. Biomater Sci 12:151\u2013163","journal-title":"Biomater Sci"},{"key":"4972_CR85","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijantimicag.2026.107745","volume":"67","author":"S Mukhopadhyay","year":"2026","unstructured":"Mukhopadhyay S, Zhang X, To KKW, Liu Y, Bai C, Leung SSY (2026) Treatment sequences of a phage and colistin combination trigger different evolution pathways of a multidrug-resistant Acinetobacter baumannii yielding distinct treatment outcomes. Int J Antimicrob Agents 67:107745","journal-title":"Int J Antimicrob Agents"},{"key":"4972_CR86","doi-asserted-by":"publisher","first-page":"567","DOI":"10.1021\/acsomega.4c07176","volume":"10","author":"U Nagarajan","year":"2025","unstructured":"Nagarajan U, Naha A, Ashok G, Balasubramanian A, Ramaiah S, S VK, Dusthackeer A, Anbarasu A, Natarajan S (2025) Biomolecular interaction of carnosine and anti-TB drug: preparation of functional biopeptide-based nanocomposites and characterization through in vitro and in silico investigations. ACS Omega 10:567\u2013587","journal-title":"ACS Omega"},{"key":"4972_CR87","doi-asserted-by":"publisher","first-page":"552","DOI":"10.1093\/cid\/civ964","volume":"62","author":"RL Nation","year":"2016","unstructured":"Nation RL, Garonzik SM, Li J, Thamlikitkul V, Giamarellos-Bourboulis EJ, Paterson DL, Turnidge JD, Forrest A, Silveira FP (2016) Updated US and European dose recommendations for intravenous colistin: how do they perform? Clin Infect Dis 62:552\u2013558","journal-title":"Clin Infect Dis"},{"key":"4972_CR88","doi-asserted-by":"publisher","DOI":"10.3389\/fddev.2026.1776167","volume":"6","author":"SK Niazi","year":"2026","unstructured":"Niazi SK (2026) Oral delivery of peptides and proteins: pharmacokinetic boundaries, negative selection, and route triage. Front Drug Deliv 6:1776167","journal-title":"Front Drug Deliv"},{"key":"4972_CR89","doi-asserted-by":"publisher","first-page":"1185","DOI":"10.1016\/j.cmi.2020.03.035","volume":"26","author":"A Nutman","year":"2020","unstructured":"Nutman A, Lellouche J, Temkin E, Daikos G, Skiada A, Durante-Mangoni E, Dishon-Benattar Y, Bitterman R, Yahav D, Daitch V, Bernardo M, Iossa D, Zusman O, Friberg LE, Mouton JW, Theuretzbacher U, Leibovici L, Paul M, Carmeli Y, Group AS (2020) Colistin plus meropenem for carbapenem-resistant Gram-negative infections: in vitro synergism is not associated with better clinical outcomes. Clin Microbiol Infect 26:1185\u20131191","journal-title":"Clin Microbiol Infect"},{"key":"4972_CR90","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1080\/1040841X.2021.1970512","volume":"48","author":"A Pal","year":"2022","unstructured":"Pal A, Bhattacharjee S, Saha J, Sarkar M, Mandal P (2022) Bacterial survival strategies and responses under heavy metal stress: a comprehensive overview. Crit Rev Microbiol 48:327\u2013355","journal-title":"Crit Rev Microbiol"},{"key":"4972_CR91","doi-asserted-by":"publisher","DOI":"10.3390\/ph18030343","volume":"18","author":"P Paranos","year":"2025","unstructured":"Paranos P, Vourli S, Pournaras S, Meletiadis J (2025) In vitro interactions between bacteriophages and antibacterial agents of various classes against multidrug-resistant metallo-beta-lactamase-producing Pseudomonas aeruginosa clinical isolates. Pharmaceuticals 18:343","journal-title":"Pharmaceuticals"},{"key":"4972_CR92","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1016\/j.jgar.2018.11.016","volume":"17","author":"HJ Park","year":"2019","unstructured":"Park HJ, Cho JH, Kim HJ, Han SH, Jeong SH, Byun MK (2019) Colistin monotherapy versus colistin\/rifampicin combination therapy in pneumonia caused by colistin-resistant Acinetobacter baumannii: a randomised controlled trial. J Glob Antimicrob Resist 17:66\u201371","journal-title":"J Glob Antimicrob Resist"},{"key":"4972_CR93","doi-asserted-by":"publisher","DOI":"10.1186\/1752-1947-8-186","volume":"8","author":"MB Pasticci","year":"2014","unstructured":"Pasticci MB, Di Filippo P, Pasqualini L, Mencacci A, Pallotto C, Malincarne L, Baldelli F (2014) Tolerability and efficacy of long-term treatment with daptomycin, ceftazidime and colistin in a patient with a polymicrobial, multidrug-resistant prosthetic joint reinfection: a case report. J Med Case Rep 8:186","journal-title":"J Med Case Rep"},{"key":"4972_CR94","doi-asserted-by":"publisher","first-page":"2388","DOI":"10.1093\/jac\/dky185","volume":"73","author":"S Pollini","year":"2018","unstructured":"Pollini S, Boncompagni S, Di Maggio T, Di Pilato V, Spanu T, Fiori B, Blasi F, Aliberti S, Sergio F, Rossolini GM, Pallecchi L (2018) In vitro synergism of colistin in combination with N-acetylcysteine against Acinetobacter baumannii grown in planktonic phase and in biofilms. J Antimicrob Chemother 73:2388\u20132395","journal-title":"J Antimicrob Chemother"},{"key":"4972_CR95","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.02033-19","volume":"64","author":"H Puja","year":"2020","unstructured":"Puja H, Bolard A, Nogu\u00e8s A, Pl\u00e9siat P, Jeannot K (2020) The efflux pump MexXY\/OprM contributes to the tolerance and acquired resistance of Pseudomonas aeruginosa to colistin. Antimicrob Agents Chemother 64:e02033-02019","journal-title":"Antimicrob Agents Chemother"},{"key":"4972_CR96","doi-asserted-by":"publisher","DOI":"10.3390\/pharmaceutics15051521","volume":"15","author":"X Qi","year":"2023","unstructured":"Qi X, Shen N, Al Othman A, Mezentsev A, Permyakova A, Yu Z, Lepoitevin M, Serre C, Durymanov M (2023) Metal-organic framework-based nanomedicines for the treatment of intracellular bacterial infections. Pharmaceutics 15:1521","journal-title":"Pharmaceutics"},{"key":"4972_CR97","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1089\/mdr.2024.0117","volume":"31","author":"J Ravi","year":"2025","unstructured":"Ravi J, Gunasekar B, Basha J (2025) Synergistic antimicrobial activity of colistin and amikacin with zinc oxide nanoparticles and their posttranscriptional regulation of mcr-1 gene expression in colistin-resistant Klebsiella pneumoniae. Microb Drug Resist 31:201\u2013210","journal-title":"Microb Drug Resist"},{"key":"4972_CR98","doi-asserted-by":"publisher","DOI":"10.7717\/peerj.18722","volume":"12","author":"P Rothong","year":"2024","unstructured":"Rothong P, Leungtongkam U, Khongfak S, Homkaew C, Samathi S, Tandhavanant S, Ngoenkam J, Vitta A, Thanwisai A, Sitthisak S (2024) Antimicrobial activity and synergistic effect of phage-encoded antimicrobial peptides with colistin and outer membrane permeabilizing agents against Acinetobacter baumannii. PeerJ 12:e18722","journal-title":"PeerJ"},{"key":"4972_CR99","doi-asserted-by":"publisher","first-page":"915","DOI":"10.1007\/s12223-025-01322-z","volume":"70","author":"D Roychowdhury","year":"2025","unstructured":"Roychowdhury D, Manna A, Mandal S, Mukherjee P, Basu A (2025) Colistin resistance in the era of antimicrobial resistance: challenges and strategic countermeasures. Folia Microbiol 70:915\u2013930","journal-title":"Folia Microbiol"},{"key":"4972_CR100","doi-asserted-by":"publisher","first-page":"437","DOI":"10.3390\/antibiotics12030437","volume":"12","author":"J Rychlickova","year":"2023","unstructured":"Rychlickova J, Kubickova V, Suk P, Urbanek K (2023) Challenges of colistin use in ICU and therapeutic drug monitoring: a literature review. Antibiotics 12:437","journal-title":"Antibiotics"},{"key":"4972_CR101","doi-asserted-by":"publisher","DOI":"10.7554\/eLife.65836","volume":"10","author":"A Sabnis","year":"2021","unstructured":"Sabnis A, Hagart KL, Klockner A, Becce M, Evans LE, Furniss RCD, Mavridou DA, Murphy R, Stevens MM, Davies JC, Larrouy-Maumus GJ, Clarke TB, Edwards AM (2021) Colistin kills bacteria by targeting lipopolysaccharide in the cytoplasmic membrane. Elife 10:e65836","journal-title":"Elife"},{"key":"4972_CR102","doi-asserted-by":"publisher","first-page":"234","DOI":"10.3390\/antibiotics11020234","volume":"11","author":"F Sacco","year":"2022","unstructured":"Sacco F, Bitossi C, Casciaro B, Loffredo MR, Fabiano G, Torrini L, Raponi F, Raponi G, Mangoni ML (2022) The antimicrobial peptide Esc(1\u201321) synergizes with colistin in inhibiting the growth and in killing multidrug resistant Acinetobacter baumannii strains. Antibiotics 11:234","journal-title":"Antibiotics"},{"key":"4972_CR103","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-022-19626-2","volume":"12","author":"S Sadyrbaeva-Dolgova","year":"2022","unstructured":"Sadyrbaeva-Dolgova S, Garc\u00eda-Fumero R, Exposito-Ruiz M, Pasquau-Lia\u00f1o J, Jim\u00e9nez-Morales A, Hidalgo-Tenorio C (2022) Incidence of nephrotoxicity associated with intravenous colistimethate sodium administration for the treatment of multidrug-resistant gram-negative bacterial infections. Sci Rep 12:15261","journal-title":"Sci Rep"},{"key":"4972_CR104","doi-asserted-by":"publisher","first-page":"85","DOI":"10.4103\/jrpp.jrpp_55_24","volume":"13","author":"AM Shabani","year":"2024","unstructured":"Shabani AM, Alikhani A, Heydari F, Hosseinnataj A, Sohrabi M, Ramezaninejad S, Ala S, Kasgari HA (2024) Evaluation of the effect of N-acetylcysteine in the prevention of colistin nephrotoxicity in critically ill patients: a randomized controlled trial. J Res Pharm Pract 13:85\u201391","journal-title":"J Res Pharm Pract"},{"key":"4972_CR105","doi-asserted-by":"publisher","DOI":"10.3389\/fvets.2025.1679761","volume":"12","author":"Y Shi","year":"2025","unstructured":"Shi Y, Mei L, Laghari ZA, Tu C, Pan Y, Zhang H, Lou Y, Lu J (2025) Silver nitrate enhances antibacterial effect of colistin against intrinsic colistin resistant Edwardsiella piscicida. Front Vet Sci 12:1679761","journal-title":"Front Vet Sci"},{"key":"4972_CR106","doi-asserted-by":"publisher","first-page":"276","DOI":"10.1021\/jacsau.2c00532","volume":"3","author":"Z Si","year":"2023","unstructured":"Si Z, Pethe K, Chan-Park MB (2023) Chemical basis of combination therapy to combat antibiotic resistance. JACS Au 3:276\u2013292","journal-title":"JACS Au"},{"key":"4972_CR107","doi-asserted-by":"publisher","first-page":"958","DOI":"10.3390\/antibiotics14100958","volume":"14","author":"S Singh","year":"2025","unstructured":"Singh S, Sahoo RK, Sahu MC (2025a) Understanding recent developments in colistin resistance: mechanisms, clinical implications, and future perspectives. Antibiotics 14:958","journal-title":"Antibiotics"},{"key":"4972_CR108","doi-asserted-by":"publisher","DOI":"10.1016\/j.microb.2025.100533","volume":"8","author":"S Singh","year":"2025","unstructured":"Singh S, Singh AK, Yadav VB, Singh SK, Sahu M, Singh AN, Nath G (2025b) In vitro efficacy of bacteriophage and colistin combinations in eradicating biofilm formed by colistin-resistant Enterobacter cloacae complex. Microbe 8:100533","journal-title":"Microbe"},{"key":"4972_CR109","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-023-33822-8","volume":"13","author":"S Sitthisak","year":"2023","unstructured":"Sitthisak S, Manrueang S, Khongfak S, Leungtongkam U, Thummeepak R, Thanwisai A, Burton N, Dhanoa GK, Tsapras P, Sagona AP (2023) Antibacterial activity of vB_AbaM_PhT2 phage hydrophobic amino acid fusion endolysin, combined with colistin against Acinetobacter baumannii. Sci Rep 13:7470","journal-title":"Sci Rep"},{"key":"4972_CR110","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1016\/j.jinf.2019.06.011","volume":"79","author":"L Sorli","year":"2019","unstructured":"Sorli L, Luque S, Li J, Campillo N, Danes M, Montero M, Segura C, Grau S, Horcajada JP (2019) Colistin for the treatment of urinary tract infections caused by extremely drug-resistant Pseudomonas aeruginosa: dose is critical. J Infect 79:253\u2013261","journal-title":"J Infect"},{"key":"4972_CR111","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/emi.2016.123","volume":"5","author":"W Sun","year":"2016","unstructured":"Sun W, Weingarten RA, Xu M, Southall N, Dai S, Shinn P, Sanderson PE, Williamson PR, Frank KM, Zheng W (2016) Rapid antimicrobial susceptibility test for identification of new therapeutics and drug combinations against multidrug-resistant bacteria. Emerg Microbes Infect 5:1\u201311","journal-title":"Emerg Microbes Infect"},{"key":"4972_CR112","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-020-18939-y","volume":"11","author":"H Sun","year":"2020","unstructured":"Sun H, Zhang Q, Wang R, Wang H, Wong Y-T, Wang M, Hao Q, Yan A, Kao RY-T, Ho P-L, Li H (2020) Resensitizing carbapenem- and colistin-resistant bacteria to antibiotics using auranofin. Nat Commun 11:5263","journal-title":"Nat Commun"},{"key":"4972_CR113","doi-asserted-by":"publisher","first-page":"2089","DOI":"10.1093\/cid\/ciab1013","volume":"74","author":"PD Tamma","year":"2022","unstructured":"Tamma PD, Aitken SL, Bonomo RA, Mathers AJ, Van Duin D, Clancy CJ (2022) Infectious Diseases Society of America guidance on the treatment of AmpC beta-lactamase-producing Enterobacterales, carbapenem-resistant Acinetobacter baumannii, and Stenotrophomonas maltophilia infections. Clin Infect Dis 74:2089\u20132114","journal-title":"Clin Infect Dis"},{"key":"4972_CR114","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1002\/phar.2209","volume":"39","author":"BT Tsuji","year":"2019","unstructured":"Tsuji BT, Pogue JM, Zavascki AP, Paul M, Daikos GL, Forrest A, Giacobbe DR, Viscoli C, Giamarellou H, Karaiskos I, Kaye D, Mouton JW, Tam VH, Thamlikitkul V, Wunderink RG, Li J, Nation RL, Kaye KS (2019) International consensus guidelines for the optimal use of the polymyxins: endorsed by the American College of Clinical Pharmacy (ACCP), European Society of Clinical Microbiology and Infectious Diseases (ESCMID), Infectious Diseases Society of America (IDSA), International Society for Anti-infective Pharmacology (ISAP), Society of Critical Care Medicine (SCCM), and Society of Infectious Diseases Pharmacists (SIDP). Pharmacotherapy 39:10\u201339","journal-title":"Pharmacotherapy"},{"key":"4972_CR115","doi-asserted-by":"publisher","first-page":"816","DOI":"10.1111\/fcp.12891","volume":"37","author":"O Unal","year":"2023","unstructured":"Unal O, Kaya O, Ozturk T, Cetin ES, Gonen I, Temel EN, Akcam FZ (2023) Evaluation of combination therapies with colistin in an experimental mouse pneumonia model induced by carbapenem-resistant Acinetobacter baumannii strain. Fundam Clin Pharmacol 37:816\u2013823","journal-title":"Fundam Clin Pharmacol"},{"key":"4972_CR116","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1007\/s11274-025-04732-w","volume":"42","author":"BS Vadaga","year":"2026","unstructured":"Vadaga BS, Sharma S, Batchu R, Dasgupta M, Kodgire P (2026) Unveiling the role of outer membrane proteins (OMPs) in biofilm formation and harnessing them for targeting biofilm-forming bacterial infections. World J Microbiol Biotechnol 42:49","journal-title":"World J Microbiol Biotechnol"},{"key":"4972_CR117","doi-asserted-by":"publisher","first-page":"691","DOI":"10.1080\/14787210.2025.2532024","volume":"23","author":"C Vrysis","year":"2025","unstructured":"Vrysis C, Kontogiannis DS, Ntourakis D, Kakoullis SA, Falagas ME (2025) Risk factors for colistin-resistant, extensively drug-resistant (XDR) and pandrug-resistant (PDR) Acinetobacter baumannii infections: a review. Expert Rev Anti Infect Ther 23:691\u2013703","journal-title":"Expert Rev Anti Infect Ther"},{"key":"4972_CR118","doi-asserted-by":"publisher","first-page":"2205","DOI":"10.1080\/22221751.2021.2002671","volume":"10","author":"X Wang","year":"2021","unstructured":"Wang X, Loh B, Gordillo Altamirano F, Yu Y, Hua X, Leptihn S (2021) Colistin-phage combinations decrease antibiotic resistance in Acinetobacter baumannii via changes in envelope architecture. Emerg Microbes Infect 10:2205\u20132219","journal-title":"Emerg Microbes Infect"},{"key":"4972_CR119","doi-asserted-by":"publisher","DOI":"10.1186\/s12866-024-03259-8","volume":"24","author":"CH Wang","year":"2024","unstructured":"Wang CH, Siu LK, Chang FY, Tsai YK, Huang LY, Lin JC (2024) Influence of PhoPQ and PmrAB two component system alternations on colistin resistance from non-mcr colistin resistant clinical E. coli strains. BMC Microbiol 24:109","journal-title":"BMC Microbiol"},{"key":"4972_CR120","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-022-06582-0","volume":"12","author":"P Wintachai","year":"2022","unstructured":"Wintachai P, Phaonakrop N, Roytrakul S, Naknaen A, Pomwised R, Voravuthikunchai SP, Surachat K, Smith DR (2022) Enhanced antibacterial effect of a novel Friunavirus phage vWU2001 in combination with colistin against carbapenem-resistant Acinetobacter baumannii. Sci Rep 12:2633","journal-title":"Sci Rep"},{"key":"4972_CR121","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-021-81140-8","volume":"11","author":"KS Witherell","year":"2021","unstructured":"Witherell KS, Price J, Bandaranayake AD, Olson J, Call DR (2021) In vitro activity of antimicrobial peptide CDP-B11 alone and in combination with colistin against colistin-resistant and multidrug-resistant Escherichia coli. Sci Rep 11:2151","journal-title":"Sci Rep"},{"key":"4972_CR122","doi-asserted-by":"publisher","DOI":"10.3389\/fmicb.2025.1603380","volume":"16","author":"M Wojciechowska","year":"2025","unstructured":"Wojciechowska M (2025) Endolysins and membrane-active peptides: innovative engineering strategies against Gram-negative bacteria. Front Microbiol 16:1603380","journal-title":"Front Microbiol"},{"key":"4972_CR123","doi-asserted-by":"publisher","first-page":"e00937","DOI":"10.1128\/spectrum.00937-22","volume":"10","author":"M Xie","year":"2022","unstructured":"Xie M, Chen K, Chan EW-C, Chen S (2022) Synergistic antimicrobial effect of colistin in combination with econazole against multidrug-resistant Acinetobacter baumannii and its persisters. Microbiol Spectr 10:e00937-e922","journal-title":"Microbiol Spectr"},{"key":"4972_CR124","doi-asserted-by":"publisher","DOI":"10.1002\/adtp.202000084","volume":"3","author":"C Xu","year":"2020","unstructured":"Xu C, Chen K, Chan KF, Chan EWC, Guo X, Chow HY, Zhao G, Zeng P, Wang M, Zhu Y, Li X, Wong KY, Chen S (2020) Imidazole type antifungal drugs are effective colistin adjuvants that resensitize colistin\u2010resistant Enterobacteriaceae. Adv Therap 3:2000084","journal-title":"Adv Therap"},{"key":"4972_CR125","doi-asserted-by":"publisher","first-page":"613","DOI":"10.1038\/s42003-022-03561-z","volume":"5","author":"C Xu","year":"2022","unstructured":"Xu C, Liu C, Chen K, Zeng P, Chan EWC, Chen S (2022) Otilonium bromide boosts antimicrobial activities of colistin against Gram-negative pathogens and their persisters. Commun Biol 5:613","journal-title":"Commun Biol"},{"key":"4972_CR126","doi-asserted-by":"publisher","DOI":"10.1016\/j.micres.2024.127879","volume":"288","author":"C Xu","year":"2024","unstructured":"Xu C, Cheng Q, Chen K, Kin So P, Jin W, Gu Y, Wong IL, Chan EWC, Wong KY, Chan KF, Chen S (2024) Repurposing cetylpyridinium chloride and domiphen bromide as phosphoethanolamine transferase inhibitor to combat colistin-resistant Enterobacterales. Microbiol Res 288:127879","journal-title":"Microbiol Res"},{"key":"4972_CR127","doi-asserted-by":"publisher","DOI":"10.1016\/j.bmc.2023.117167","volume":"79","author":"JKH Yam","year":"2023","unstructured":"Yam JKH, Tan LZW, Hong Z, Salido MMS, Woo BY, Yong AMH, Tan CaZ, Li SFY, Yang L, Givskov M, Chng SS (2023) Auranofin inhibits virulence pathways in Pseudomonas aeruginosa. Bioorg Med Chem 79:117167","journal-title":"Bioorg Med Chem"},{"key":"4972_CR128","doi-asserted-by":"publisher","DOI":"10.1186\/s12879-025-11401-8","volume":"25","author":"P Yang","year":"2025","unstructured":"Yang P, Shuai W, Ju Y, Zhu H, Wang R, Lu X, Jiang S (2025a) Acute kidney injury of intravenous colistin sulfate compared with colistimethate sodium: a real-world, retrospective cohort study. BMC Infect Dis 25:1007","journal-title":"BMC Infect Dis"},{"key":"4972_CR129","doi-asserted-by":"publisher","first-page":"4562","DOI":"10.1007\/s12035-024-04577-8","volume":"62","author":"R Yang","year":"2025","unstructured":"Yang R, Xiang D, Yuan F, Yang Y, Wang P, Xu B, Li X (2025b) Unraveling neurotoxicity discrepancies: comparative in vitro and in vivo analysis of colistin and polymyxin B and the underlying mechanisms. Mol Neurobiol 62:4562\u20134575","journal-title":"Mol Neurobiol"},{"key":"4972_CR130","doi-asserted-by":"publisher","DOI":"10.3389\/fcimb.2025.1729919","volume":"15","author":"T Yang","year":"2025","unstructured":"Yang T, Li H, Xu X, An J, Zhang Z, Li B, Dou Z (2025c) Colistin-based combination therapy versus monotherapy for carbapenem-resistant gram-negative bacterial infections: a systematic review and meta-analysis. Front Cell Infect Microbiol 15:1729919","journal-title":"Front Cell Infect Microbiol"},{"key":"4972_CR131","doi-asserted-by":"publisher","DOI":"10.1093\/nar\/gkaf984","volume":"53","author":"Y Yang","year":"2025","unstructured":"Yang Y, Kang D, Mihalache B, Vexler S, Jain S, Peng H, Annabi N, Yang S, Chen IA (2025d) Metagenome-inspired libraries to engineer phage M13 for targeted killing of Gram-negative bacterial species. Nucleic Acids Res 53:gkaf984","journal-title":"Nucleic Acids Res"},{"key":"4972_CR132","doi-asserted-by":"publisher","DOI":"10.3390\/cryst12111513","volume":"12","author":"MT Yassin","year":"2022","unstructured":"Yassin MT, Al-Askar AA, Maniah K, Al-Otibi FO (2022) Green synthesis of zinc oxide nanocrystals utilizing Origanum majorana leaf extract and their synergistic patterns with colistin against multidrug-resistant bacterial strains. Crystals 12:1513","journal-title":"Crystals"},{"key":"4972_CR133","doi-asserted-by":"publisher","first-page":"794","DOI":"10.1378\/chest.72.6.794","volume":"72","author":"TT Yoshikawa","year":"1977","unstructured":"Yoshikawa TT, Bayer AS, Guze LB (1977) Endocarditis due to Pseudomonas aeruginosa in a heroin addict: successful treatment with trimethoprim-sulfamethoxazole mixture plus colistin. Chest 72:794\u2013796","journal-title":"Chest"},{"key":"4972_CR134","doi-asserted-by":"publisher","DOI":"10.3389\/fmicb.2023.1153366","volume":"14","author":"Q Yuan","year":"2023","unstructured":"Yuan Q, Xia P, Xiong L, Xie L, Lv S, Sun F, Feng W (2023) First report of coexistence of bla (KPC-2)-, bla (NDM-1)- and mcr-9-carrying plasmids in a clinical carbapenem-resistant Enterobacter hormaechei isolate. Front Microbiol 14:1153366","journal-title":"Front Microbiol"},{"key":"4972_CR135","doi-asserted-by":"publisher","first-page":"655","DOI":"10.1007\/s40262-025-01488-2","volume":"64","author":"PJ Zamri","year":"2025","unstructured":"Zamri PJ, Lim SMS, Sime FB, Roberts JA, Abdul-Aziz MH (2025) A systematic review of pharmacokinetic studies of colistin and polymyxin B in adult populations. Clin Pharmacokinet 64:655\u2013689","journal-title":"Clin Pharmacokinet"},{"key":"4972_CR136","doi-asserted-by":"publisher","DOI":"10.1016\/j.foodchem.2023.135647","volume":"413","author":"P Zeng","year":"2023","unstructured":"Zeng P, Zhang P, Yi L, Wong KY, Chen S, Chan KF, Leung SSY (2023) A novel ESKAPE-sensitive peptide with enhanced stability and its application in controlling multiple bacterial contaminations in chilled fresh pork. Food Chem 413:135647","journal-title":"Food Chem"},{"key":"4972_CR137","doi-asserted-by":"publisher","DOI":"10.1016\/j.biotechadv.2024.108371","volume":"73","author":"P Zeng","year":"2024","unstructured":"Zeng P, Wang H, Zhang P, Leung SSY (2024) Unearthing naturally-occurring cyclic antibacterial peptides and their structural optimization strategies. Biotechnol Adv 73:108371","journal-title":"Biotechnol Adv"},{"key":"4972_CR138","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1016\/j.flm.2017.07.001","volume":"1","author":"W Zhang","year":"2017","unstructured":"Zhang W, Aurosree B, Gopalakrishnan B, Balada-Llasat J-M, Pancholi V, Pancholi P (2017) The role of LpxA\/C\/D and pmrA\/B g ene systems in colistin-resistant clinical strains of Acinetobacter baumannii. Front Lab Med 1:86\u201391","journal-title":"Front Lab Med"},{"key":"4972_CR139","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.2119417119","volume":"119","author":"Q Zhang","year":"2022","unstructured":"Zhang Q, Wang R, Wang M, Liu C, Koohi-Moghadam M, Wang H, Ho PL, Li H, Sun H (2022) Re-sensitization of mcr carrying multidrug resistant bacteria to colistin by silver. Proc Natl Acad Sci U S A 119:e2119417119","journal-title":"Proc Natl Acad Sci U S A"},{"key":"4972_CR140","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijbiomac.2024.134670","volume":"278","author":"P Zhang","year":"2024","unstructured":"Zhang P, Zeng P, Lai CK, Ip M, To KK, Zuo Z, Xia J, Leung SS (2024a) Synergism of colistin and globular endolysins against multidrug-resistant gram-negative bacteria. Int J Biol Macromol 278:134670","journal-title":"Int J Biol Macromol"},{"key":"4972_CR141","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijantimicag.2023.107031","volume":"63","author":"Y Zhang","year":"2024","unstructured":"Zhang Y, Dong R, Huang Y, Ling X, Ye Z, Jiang S (2024b) Acute kidney injury associated with colistin sulfate vs. polymyxin B sulfate therapy: a real-world, retrospective cohort study. Int J Antimicrob Agents 63:107031","journal-title":"Int J Antimicrob Agents"},{"key":"4972_CR142","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2024.1466888","volume":"15","author":"Y Zhang","year":"2024","unstructured":"Zhang Y, Wang C, Chen J, Bai C, Sun D, Qiu Y, Teng M, Dong Y (2024c) Efficacy, safety, and therapeutic drug monitoring of polymyxin B sulfate and colistin sulfate in critically ill patients: a real-world retrospective study. Front Pharmacol 15:1466888","journal-title":"Front Pharmacol"}],"container-title":["Archives of Microbiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00203-026-04972-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00203-026-04972-w","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00203-026-04972-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T09:02:20Z","timestamp":1785574940000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00203-026-04972-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,25]]},"references-count":142,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2026,8]]}},"alternative-id":["4972"],"URL":"https:\/\/doi.org\/10.1007\/s00203-026-04972-w","relation":{},"ISSN":["0302-8933","1432-072X"],"issn-type":[{"value":"0302-8933","type":"print"},{"value":"1432-072X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,25]]},"assertion":[{"value":"27 March 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 May 2026","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 May 2026","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 May 2026","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no conflicts of interest.","order":1,"name":"Ethics","label":"Conflicts of interest","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"408"}}